Inventisbio Co., Ltd
Clinical trials sponsored by Inventisbio Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Liver function may change how D-2570 works in the body Results expected Oct 2026 (estimated)
- Kidney function may change how D-2570 works in the body Results expected Nov 2026 (estimated)
- New pill could offer hope for advanced breast cancer patients Results expected Nov 2026 (estimated)
- New pill could tame tough psoriasis without injections Results expected Jul 2027 (estimated)
- New psoriasis pill shows promise in major trial Results expected Jul 2027 (estimated)
-
New drug combo aims to tame stubborn gout flares
Disease control CompletedThis study tests whether adding an investigational drug called D-0120 to the standard gout medication allopurinol can lower uric acid levels more effectively than allopurinol alone. The trial enrolls adults with gout who have had at least two flares in the past year and whose uri…
Phase 2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New pill D-2570 shows promise against stubborn psoriasis in early trial
Disease control CompletedThis phase 2 clinical trial tested an experimental oral drug called D-2570 in 161 adults with moderate-to-severe plaque psoriasis. Participants were randomly assigned to one of three doses of D-2570 or a placebo for 12 weeks. The main goal was to see how many people achieved at l…
Phase 2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Healthy volunteers help test new Drug's safety
Knowledge-focused CompletedThis early-stage study tested the safety and how the body handles a new drug called D-2570 in 100 healthy adults aged 18 to 45. Participants took either the drug or a placebo, and researchers measured side effects, vital signs, and drug levels in the blood. The goal was to gather…
Phase 1 • Sponsor: InventisBio Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC